{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:57:48Z","timestamp":1791295068349,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T00:00:00Z","timestamp":1380844800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0075518","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T21:20:47Z","timestamp":1380921647000},"page":"e75518","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":80,"title":["Improved Mass Spectrometry Assay For Plasma Hepcidin: Detection and Characterization of a Novel Hepcidin Isoform"],"prefix":"10.1371","volume":"8","author":[{"given":"Coby M. M.","family":"Laarakkers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin T.","family":"Wiegerinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siem","family":"Klaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kolodziejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Gille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Hohlbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Tjalsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorine W.","family":"Swinkels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,10,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1373\/clinchem.2009.140053","article-title":"Hepcidin in human iron disorders: diagnostic implications","volume":"257","author":"JJ Kroot","year":"2011","journal-title":"Clin Chem"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1074\/jbc.M008922200","article-title":"Hepcidin, a urinary antimicrobial peptide synthesized in the liver","volume":"276","author":"CH Park","year":"2001","journal-title":"J Biol Chem"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1182\/blood-2005-05-1873","article-title":"Novel urine hepcidin assay by mass spectrometry","volume":"106","author":"E Kemna","year":"2005","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1373\/clinchem.2006.079186","article-title":"Mass spectrometry-based hepcidin measurements in serum and urine: analytical aspects and clinical implications","volume":"53","author":"EH Kemna","year":"2007","journal-title":"Clin Chem"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e2706","DOI":"10.1371\/journal.pone.0002706","article-title":"Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry","volume":"3","author":"DW Swinkels","year":"2008","journal-title":"PLoS ONE"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1373\/clinchem.2010.149187","article-title":"Immunochemical and Mass-Spectrometry-Based Serum Hepcidin Assays for Iron Metabolism Disorders","volume":"256","author":"JJC Kroot","year":"2010","journal-title":"Clin Chem"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jprot.2012.08.006","article-title":"Serum levels of the hepcidin-20 isoform in a large general population: The Val Borbera study","volume":"76","author":"N Campostrini","year":"2012","journal-title":"J Proteomics"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1182\/blood-2005-10-4043","article-title":"Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System","volume":"108","author":"N Tomosugi","year":"2006","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1093\/ndt\/gfp546","article-title":"Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate","volume":"25","author":"HP Peters","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"329646","DOI":"10.1155\/2010\/329646","article-title":"Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS","volume":"2010","author":"N Campostrini","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bcmd.2009.03.008","article-title":"Activation and inactivation of the iron hormone hepcidin: Biochemical characterization of prohepcidin cleavage and sequential degradation to N-terminally truncated hepcidin isoforms","volume":"43","author":"M Schranz","year":"2009","journal-title":"Blood Cells Mol Dis"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bcmd.2007.07.009","article-title":"Posttranslational processing of hepcidin in human hepatocytes is mediated by the prohormone convertase furin","volume":"40","author":"EV Valore","year":"2008","journal-title":"Blood Cells Mol Dis"},{"key":"ref13","first-page":"3672","article-title":"Hepcidin and hemoglobin content parameters in the diagnosis of iron deficiency in rheumatoid arthritis patients with anemia. Arthritis Rheum","volume":"63","author":"S van Santen","year":"2011"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"e23109","DOI":"10.1371\/journal.pone.0023109","article-title":"Hepcidin levels and their determinants in different types of myelodysplastic syndromes","volume":"6","author":"V Santini","year":"2011","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1182\/blood-2011-06-364034","article-title":"TMPRSS6 rs855791 modulates hepcidin transcription in vitro and serum hepcidin levels in normal individuals","volume":"118","author":"A Nai","year":"2011","journal-title":"Blood"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1093\/ndt\/gfs164","article-title":"Intra-individual variability of serum hepcidin-25 in haemodialysis patients using mass spectrometry and ELISA","volume":"27","author":"HP Peters","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3324\/haematol.2012.077446","article-title":"Inappropriately low hepcidin levels in patients with myelodysplastic syndrome carrying a somatic mutation of SF3B1","volume":"98","author":"I Ambaglio","year":"2013","journal-title":"Haematologica"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1373\/clinchem.2012.194977","article-title":"Diurnal rhythm rather than dietary iron mediates daily hepcidin variations","volume":"59","author":"CC Schaap","year":"2013","journal-title":"Clin Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1477-5956-6-28","article-title":"SELDI-TOF-MS determination of hepcidin in clinical samples using stable isotope labelled hepcidin as an internal standard","volume":"6","author":"DG Ward","year":"2008","journal-title":"Proteome Sci"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1002\/rcm.3319","article-title":"Simple and sensitive quantification of bioactive peptides in biological matrices using liquid chromatography\/selected reaction monitoring mass spectrometry coupled with trichloroacetic acid clean-up","volume":"21","author":"N Murao","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1373\/clinchem.2008.107029","article-title":"Quantification of hepcidin-25 in human serum by isotope dilution micro-HPLC-tandem mass spectrometry","volume":"54","author":"U Kobold","year":"2008","journal-title":"Clin Chem"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.vascn.2009.02.004","article-title":"Development of a method for the sensitive and quantitative determination of hepcidin in human serum using LC-MS\/MS","volume":"59","author":"H Li","year":"2009","journal-title":"J Pharmacol Toxicol Methods"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1002\/rcm.4512","article-title":"Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer","volume":"24","author":"SS Bansal","year":"2010","journal-title":"Rapid Commun Mass Spectrom"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1021\/ac2020905","article-title":"Design and validation of a high-throughput matrix-assisted laser desorption ionization time-of-flight mass spectrometry method for quantification of hepcidin in human plasma","volume":"83","author":"DS Anderson","year":"2011","journal-title":"Anal Chem"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/ajh.23289","article-title":"Second round robin for plasma hepcidin methods: first steps toward harmonization","volume":"87","author":"JJ Kroot","year":"2012","journal-title":"Am J Hematol"},{"key":"ref26","first-page":"1748","article-title":"Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica","volume":"94","author":"JJ Kroot","year":"2009"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"37597","DOI":"10.1074\/jbc.M205305200","article-title":"The solution structure of human hepcidin, a peptide hormone with antimicrobial activity that is involved in iro uptake and hereditary hemochromatosis","volume":"277","author":"HN Hunter","year":"2002","journal-title":"J Biol Chem"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1182\/blood-2006-11-058560","article-title":"Effect of the new HJV-L165X mutation on penetrance of HFE","volume":"109","author":"BA van Dijk","year":"2007","journal-title":"Blood"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Hohlbaum AM, Trentman S, Gille H, Allersdorfer A, Belaiba RS, <etal>et al<\/etal>.. (2011) Discovery and Preclinical Characterization of a Novel Hepcidin Antagonist with Tunable PK\/PD Properties for the Treatment of Anemia in Different Patient Populations Blood 118: Abstract 687.","DOI":"10.1182\/blood.V118.21.687.687"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"8198","DOI":"10.1073\/pnas.0813399106","article-title":"An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies","volume":"106","author":"D Sch\u00f6nfeld","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1002\/pro.5560041120","article-title":"How to measure and predict the molar absorption coefficient of a protein","volume":"4","author":"CN Pace","year":"1995","journal-title":"Protein Sci"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1126\/science.1104742","article-title":"Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization","volume":"306","author":"E Nemeth","year":"2004","journal-title":"Science"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2005-05-2049","article-title":"The N-terminus of hepcidin is essential for its interaction with ferroportin: structure-function study","volume":"107","author":"E Nemeth","year":"2006","journal-title":"Blood"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1182\/blood-2005-04-1766","article-title":"Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs","volume":"106","author":"S Rivera","year":"2005","journal-title":"Blood"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.cca.2011.12.015","article-title":"Preanalytical factors and reference intervals for serum hepcidin LC-MS\/MS method","volume":"413","author":"O Itkonen","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ab.2009.03.039","article-title":"(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies","volume":"389","author":"JJ Kroot","year":"2009","journal-title":"Anal Biochem"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"4292","DOI":"10.1182\/blood-2008-02-139915","article-title":"Immunoassay for human serum hepcidin","volume":"112","author":"T Ganz","year":"2008","journal-title":"Blood"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0075518","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T09:16:48Z","timestamp":1596619008000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0075518"}},"subtitle":[],"editor":[{"given":"Harpal Singh","family":"Randeva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,10,4]]},"references-count":37,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2013,10,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0075518","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,4]]}}}